Contributors 4003

May 1, 2006

1 Min Read

Originally Published MX May/June 2006


To keep their companies on track, medtech executives must continually be watching over changing market conditions, finance trends, investor relations, and public policy issues that could affect their business planning. In light of their numerous obligations, company leaders can lose sight of the foundations on which their companies are built: the devices themselves. Continual evaluation of a company's product portfolio and future pipeline is key to sustaining growth.

In this issue, MX explores multiple dimensions of medtech product development, from forecasting customers' future technology needs to handling postmarket safety issues in a changing regulatory climate.

Market Analysis


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like